Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Short-term Investments: 2015-2025

Historic Short-term Investments for CorMedix (CRMD) over the last 9 years, with Sep 2025 value amounting to $8.1 million.

  • CorMedix's Short-term Investments fell 24.69% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year decrease of 24.69%. This contributed to the annual value of $11.0 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, CorMedix's Short-term Investments is $8.1 million, which was down 74.24% from $31.4 million recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Short-term Investments peaked at $33.3 million during Q3 2023, and registered a low of $5.0 million during Q1 2021.
  • Its 3-year average for Short-term Investments is $20.9 million, with a median of $20.2 million in 2024.
  • Its Short-term Investments has fluctuated over the past 5 years, first surged by 228.77% in 2022, then plummeted by 67.71% in 2024.
  • CorMedix's Short-term Investments (Quarterly) stood at $12.1 million in 2021, then rose by 28.77% to $15.6 million in 2022, then soared by 111.31% to $33.3 million in 2023, then tumbled by 67.71% to $11.0 million in 2024, then declined by 24.69% to $8.1 million in 2025.
  • Its Short-term Investments was $8.1 million in Q3 2025, compared to $31.4 million in Q2 2025 and $11.2 million in Q1 2025.